SCHEMBL6166381

SCHEMBL6166381

CC1(C)CCC(=O)c2c(C3CC3c3ccccc3)nn(CC(F)(F)F)c21

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.34
TACR1 P25103 1/20 0.33
BACE1 P56817 1/20 0.32
POLQ O75417 2/20 0.31
RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166383 1.00 KDM1A (0.34) KDM1ATACR1BACE1POLQRIPK1
SCHEMBL6164521 0.84 TACR1 (0.33) KDM1ATACR1BACE1POLQRIPK1
SCHEMBL6164522 0.84 TACR1 (0.33) KDM1ATACR1BACE1POLQRIPK1
SCHEMBL6167238 0.80 HDAC9 (0.31)
SCHEMBL6165500 0.78 PTGS2 (0.38) POLQ
SCHEMBL6165166 0.74 USP19 (0.33) POLQ
SCHEMBL6163634 0.73 CCNA2 (0.39)
SCHEMBL6163631 0.73 CCNA2 (0.39)
SCHEMBL6167609 0.71 CDC7 (0.37)
SCHEMBL6161815 0.71 ADORA1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed